Neuland Laboratories Ltd
NSE: NEULANDLAB BSE: 524558
₹19955
-245 (1.21%)
Fri, 23 Oct 2026, 03:57 am
Market Cap (in Cr)25916.82
PE Ratio51.43
Dividend0.17
Health Technology
Pharmaceuticals: Major
24.5KNeuland Laboratories Financials
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.63B | 2.02B | 2.18B | 3.07B | 2.78B | 3.94B | 4.49B | 4.61B | 4.66B | 4.58B | 4.97B | 5.67B | 5.13B | 6.46B | 7.42B | 9.24B | 9.34B | 11.76B | 15.35B | 14.54B |
| Gross profit | 907.75M | 464.47M | 241.51M | 312.48M | 471.16M | 652.88M | 745.00M | 877.55M | 1.14B | 915.62M | 1.12B | 1.34B | 818.69M | 665.05M | 1.27B | 1.97B | 1.49B | 3.07B | 4.99B | 3.82B |
| Operating expenses (excl. COGS) | -282.97M | -330.15M | -30.78M | -44.47M | -344.85M | -359.06M | -372.37M | -408.69M | -556.39M | -415.81M | -488.98M | -565.26M | -672.69M | -495.09M | -745.21M | -994.04M | -694.03M | -908.19M | -1.13B | -1.34B |
| Selling/general/admin expenses, total | -262.50M | -330.80M | — | — | -300.34M | -331.80M | -363.19M | -396.22M | -539.84M | -485.39M | -588.15M | -546.41M | -651.87M | -483.45M | -658.13M | -819.69M | -599.13M | -861.54M | -1.05B | -1.28B |
| Research & development | -37.61M | -52.11M | -59.69M | -86.49M | -100.27M | -102.45M | -111.09M | -90.26M | -108.26M | -106.52M | -109.52M | -119.52M | -140.51M | -166.32M | -174.12M | -210.66M | -3.64M | -3.01M | -435.00M | -612.40M |
| Selling/general/admin expenses, other | -224.90M | -278.69M | — | — | -200.07M | -229.35M | -252.10M | -305.96M | -431.58M | -378.87M | -478.63M | -426.89M | -511.37M | -317.13M | -484.02M | -609.03M | -595.49M | -858.53M | -610.08M | -666.72M |
| Other operating expenses, total | -20.47M | 650.00K | -30.78M | -44.47M | -44.51M | -27.26M | -9.18M | -12.47M | -16.55M | 69.59M | 99.17M | -18.84M | -20.81M | -11.63M | -87.08M | -174.34M | -94.90M | -46.65M | -80.72M | -56.17M |
| Operating income | 138.21M | 134.32M | 151.04M | 181.52M | 126.31M | 293.82M | 372.63M | 468.86M | 583.78M | 499.81M | 627.05M | 769.94M | 146.00M | 169.96M | 525.26M | 978.10M | 800.53M | 2.17B | 3.87B | 2.48B |
| Non-operating income, total | -52.33M | -35.71M | -45.92M | -38.18M | -224.60M | -240.91M | -364.32M | -311.09M | -238.24M | -252.59M | -207.02M | -98.08M | -6.66M | 33.41M | 3.97M | 75.24M | 21.10M | -8.79M | 148.21M | 979.78M |
| Interest expense, net of interest capitalized | -33.99M | -38.72M | -60.58M | -105.32M | -208.87M | -240.92M | -275.78M | -219.49M | -236.48M | -273.61M | -244.78M | -210.87M | -189.28M | -156.63M | -215.74M | -178.98M | -134.95M | -130.67M | -139.97M | -82.97M |
| Interest capitalized | 0 | 0 | 0 | 0 | 26.19M | 0 | 0 | 0 | 0 | 0 | 8.70M | 0 | 31.97M | 95.32M | 27.55M | 11.42M | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | -18.34M | 3.01M | 14.66M | 67.14M | -27.70M | 10.00K | -88.54M | -93.85M | -716.00K | 21.02M | 37.76M | 112.79M | 182.62M | 190.04M | 219.70M | 254.22M | 156.05M | 48.05M | 285.37M | 984.99M |
| Non-operating interest income | 3.24M | 5.01M | 4.04M | 7.03M | 8.32M | 9.27M | 9.75M | 10.38M | 8.36M | 7.84M | 7.50M | 10.58M | 7.89M | 24.96M | 21.62M | 16.68M | 9.95M | 15.56M | 82.27M | 102.53M |
| Miscellaneous non-operating expense | -21.59M | -2.00M | 10.62M | 60.11M | -36.02M | -9.26M | -98.29M | -104.23M | -9.08M | 13.19M | 30.26M | 102.21M | 174.73M | 165.08M | 198.08M | 237.55M | 146.10M | 32.48M | 203.10M | 882.46M |
| Unusual income/expense | — | — | — | — | 11.97M | — | — | 2.25M | -1.05M | — | — | — | — | — | — | 0 | 0 | 73.84M | 2.82M | 77.76M |
| Pretax income | 85.88M | 98.61M | 105.12M | 143.34M | -98.29M | 52.91M | 8.31M | 157.77M | 345.54M | 247.22M | 420.03M | 671.86M | 139.34M | 203.37M | 529.23M | 1.05B | 821.62M | 2.16B | 4.01B | 3.46B |
| Taxes | -23.52M | -8.23M | 8.40M | -24.14M | 29.08M | -230.00K | 17.39M | -19.58M | -78.00M | -87.90M | -149.24M | -203.21M | -18.71M | -38.96M | -367.12M | -247.03M | -183.41M | -522.29M | -1.01B | -862.21M |
| Non-controlling/minority interest | — | 0 | 0 | 30.00K | 160.00K | 210.00K | -90.00K | 440.00K | 535.00K | 148.00K | 2.45M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | — | 0 | 0 | — | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 62.36M | 90.38M | 113.52M | 119.23M | -69.05M | 52.89M | 25.61M | 138.63M | 268.07M | 159.47M | 273.25M | 468.65M | 120.63M | 164.42M | 162.10M | 806.31M | 638.22M | 1.64B | 3.00B | 2.60B |
| Net income | 62.36M | 90.38M | 113.52M | 119.23M | -69.05M | 52.89M | 25.61M | 138.63M | 268.07M | 159.47M | 273.25M | 468.65M | 120.63M | 164.42M | 162.10M | 806.31M | 638.22M | 1.64B | 3.00B | 2.60B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 62.36M | 90.38M | 113.52M | 119.23M | -69.05M | 52.89M | 25.61M | 138.63M | 268.07M | 159.47M | 273.25M | 468.65M | 120.63M | 164.42M | 162.10M | 806.31M | 638.22M | 1.64B | 3.00B | 2.60B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 693.88M | 190.54M | 207.34M | 255.22M | 261.91M | 447.93M | 521.54M | 615.08M | 733.16M | 653.01M | 784.48M | 962.22M | 367.04M | 428.59M | 838.06M | 1.37B | 1.29B | 2.69B | 4.46B | 3.14B |
| EBIT | 624.78M | 134.32M | 151.04M | 181.52M | 126.31M | 293.82M | 372.63M | 468.86M | 583.78M | 499.81M | 627.05M | 769.94M | 146.00M | 169.96M | 525.26M | 978.10M | 800.53M | 2.17B | 3.87B | 2.48B |
| Total operating expenses | 0 | -1.89B | -2.03B | -2.89B | -2.66B | -3.64B | -4.11B | -4.14B | -4.07B | -4.08B | -4.34B | -4.90B | -4.98B | -6.29B | -6.90B | -8.26B | -8.54B | -9.59B | -11.48B | -12.05B |
| Prepaid expenses | 44.73M | 87.41M | 80.49M | 79.92M | 90.54M | 22.82M | 28.38M | 36.27M | 60.65M | 127.97M | 181.58M | 35.72M | 49.29M | 57.75M | 60.83M | 71.75M | 74.16M | 105.38M | 111.41M | 117.18M |
| Deferred income, current | — | — | — | — | — | — | — | — | 31.86M | 31.64M | 217.68M | 209.73M | 88.17M | 148.12M | 216.72M | 636.07M | 632.22M | 1.37B | 811.73M | 726.42M |
| Capital and operating lease obligations | 4.81M | 7.85M | 9.42M | 13.07M | 18.21M | 10.69M | 3.07M | 5.36M | 981.00K | 0 | 0 | 0 | 0 | 0 | 25.78M | 95.86M | 69.40M | 38.48M | 92.03M | 186.18M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 52.25M | 76.25M | 165.84M | 218.50M | — | — | — | 216.25M | 206.23M | 196.30M | 197.67M | 456.58M | 645.51M | 807.56M | 666.78M | 694.20M | 566.99M | 582.99M | 728.89M | 761.58M |
| Deferred income, non-current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 202.80M | 202.80M | 202.80M | 300.00K | 0 | — | — | — |
| Minority interest | 0 | 0 | 0 | 120.00K | 3.70M | 3.49M | 3.58M | 3.14M | 2.60M | 2.45M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -7.40M | -12.47M | -15.58M | -15.78M | -22.10M | 0 | 0 | 0 | -10.66M | -26.65M | -15.95M | -12.20M | 0 | 0 | -49.49M | -25.66M | -38.49M | -64.15M | -128.30M | -179.62M |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
